🇺🇸 ROIV — Roivant Sciences Ltd.

Salud Compra fuerte
← Volver

Precio actual

36,04 USD

Máx. histórico

41,81

55 días

Caída desde máximo

-13,80%

Rango 52 semanas

19,32 – 42,50

Variación hoy

+0,42%

Cierre anterior

35,89

Rango de hoy

35,56 – 36,78

Volumen hoy

6.686.435

Peor caída histórica

-79,22%

20/12/2021 → 12/05/2022

Recuperado en 1217 días

Volatilidad anualizada ⓘ

55,48%

Información
Nombre completo
Roivant Sciences Ltd.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
721
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
50,00 USD (puede no estar actualizado)
Primera cotización
08/12/2020
Precio actualizado
hace 1 hora
Sobre la empresa

Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody targeting FcRn in development across several IgG-mediated autoimmune indications; mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease; neonatal fragment crystallizable receptor for the treatment of graves' disease, difficult-to-treat rheumatoid arthritis, sjögren's disease, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and cutaneous lupus erythematosus indications; batoclimab, a fully human monoclonal antibody for the treatment of thyroid eye disease; and brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis, cutaneous sarcoidosis, and other immune-mediated diseases. The company's lead program consists of mosliciguat, an inhaled sGC activator for the treatment of pulmonary hypertension associated with interstitial lung disease and other cardiopulmonary diseases. In addition, the company offers delivery platforms comprising a lipid nanoparticle (LNP) platform and a ligand conjugate platform. Roivant Sciences Ltd. was founded in 2014 and is based in London, United Kingdom.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
14/07/2025 11,37 11,65 11,30 11,63 +2,38% 3,08% 4.767.000
11/07/2025 11,48 11,53 11,29 11,36 -1,82% 2,09% 5.079.600
10/07/2025 11,27 11,58 11,19 11,57 +3,12% 3,46% 8.065.600
09/07/2025 10,92 11,39 10,92 11,22 +3,31% 4,30% 12.177.500
08/07/2025 10,71 10,94 10,71 10,86 +1,12% 2,15% 7.728.200
07/07/2025 10,91 10,95 10,72 10,74 -2,27% 2,11% 5.116.800
03/07/2025 11,01 11,03 10,94 10,99 +0,18% 0,86% 3.307.200
02/07/2025 10,89 11,08 10,83 10,97 +0,27% 2,25% 11.140.800
01/07/2025 11,22 11,32 10,92 10,94 -2,93% 3,57% 14.004.400
30/06/2025 11,39 11,43 11,23 11,27 -1,05% 1,77% 6.440.300
27/06/2025 11,53 11,58 11,25 11,39 -1,81% 2,91% 11.126.700
26/06/2025 11,40 11,62 11,32 11,60 +1,75% 2,63% 6.021.600
25/06/2025 11,64 11,66 11,32 11,40 -1,21% 2,96% 7.312.700
24/06/2025 11,59 11,82 11,47 11,54 +0,35% 3,02% 7.284.400
23/06/2025 11,37 11,65 11,36 11,50 +0,44% 2,55% 5.421.100
20/06/2025 11,50 11,60 11,32 11,45 +0,09% 2,43% 18.150.000
18/06/2025 11,15 11,79 11,11 11,44 +2,97% 6,06% 7.918.300
17/06/2025 11,03 11,16 10,89 11,11 +0,27% 2,40% 6.173.900
16/06/2025 11,38 11,45 10,96 11,08 -2,12% 4,35% 6.064.700
13/06/2025 11,32 11,51 11,26 11,32 -1,31% 2,21% 5.969.100
12/06/2025 11,17 11,48 11,11 11,47 +1,68% 3,31% 3.985.600
11/06/2025 11,46 11,51 11,27 11,28 -0,79% 2,09% 4.075.100
10/06/2025 11,07 11,42 11,04 11,37 +2,62% 3,39% 7.469.600
09/06/2025 11,32 11,33 10,99 11,08 -1,34% 3,00% 3.587.000
06/06/2025 11,31 11,44 11,11 11,23 +0,27% 2,92% 4.928.000
05/06/2025 11,23 11,34 11,05 11,20 -0,09% 2,58% 5.918.400
04/06/2025 11,20 11,55 11,20 11,21 -0,31% 3,17% 5.089.700
03/06/2025 11,18 11,32 11,09 11,25 +0,67% 2,06% 5.099.000
02/06/2025 10,99 11,35 10,96 11,17 +1,64% 3,55% 7.583.500
30/05/2025 11,30 11,34 10,88 10,99 -2,74% 4,12% 7.126.100